Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beige

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 24, 1997
Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisalR Kunz, R Kreutz, J Beige, et al.
Journal of Hypertension|July 15, 1999
Angiotensinogen M235T variant and salt sensitivity in young normotensive CaucasiansU Schorr, K Blaschke, J Beige, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Monitoring dialysis efficacy by comparing delivered and predicted Kt/VJ Beige, A M Sharma, A Distler, et al.
Journal of Hypertension|August 10, 2000
G-protein beta3 subunit 825T allele and response to dietary salt in normotensive menU Schorr, K Blaschke, J Beige, et al.
Biomolecules|June 26, 2025
The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?Sajjad Biglari, Harald Mischak, Joachim Beige, et al.
Der Internist|September 8, 2020
[Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy]J Beige, J Drube, H von der Leyen, et al.
Journal of Hypertension|March 8, 2017
Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapyJoachim Beige, Theresa Jentzsch, Ralph Wendt, et al.
Molecular Medicine (Cambridge, Mass.)|October 29, 2024
MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentialsMeng Lou, Lian Zou, Liying Zhang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 26, 2011
Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patientsR U Pliquett, C Klein, T Grünewald, et al.
Plos One|November 22, 2013
Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trialMatthias Huber, Till Treutler, Peter Martus, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
Hypertension (Dallas, Tex. : 1979)|December 24, 1997
Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisalR Kunz, R Kreutz, J Beige, et al.
Journal of Hypertension|July 15, 1999
Angiotensinogen M235T variant and salt sensitivity in young normotensive CaucasiansU Schorr, K Blaschke, J Beige, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Monitoring dialysis efficacy by comparing delivered and predicted Kt/VJ Beige, A M Sharma, A Distler, et al.
Journal of Hypertension|August 10, 2000
G-protein beta3 subunit 825T allele and response to dietary salt in normotensive menU Schorr, K Blaschke, J Beige, et al.
Biomolecules|June 26, 2025
The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?Sajjad Biglari, Harald Mischak, Joachim Beige, et al.
Der Internist|September 8, 2020
[Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy]J Beige, J Drube, H von der Leyen, et al.
Journal of Hypertension|March 8, 2017
Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapyJoachim Beige, Theresa Jentzsch, Ralph Wendt, et al.
Molecular Medicine (Cambridge, Mass.)|October 29, 2024
MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentialsMeng Lou, Lian Zou, Liying Zhang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 26, 2011
Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patientsR U Pliquett, C Klein, T Grünewald, et al.
Plos One|November 22, 2013
Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trialMatthias Huber, Till Treutler, Peter Martus, et al.
Pageof 20